![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
20
Southwest Synthetic Pharmaceutical Corporation, Limited Chongqing Cn, based in China, is a pharmaceutical company.
One of their significant offerings is Sulfamethoxazole, supported by a 'Withdrawn by EDQM Failure to CEP procedure' Certificate of Suitability (CEP) with the number R1-CEP 1999-097 - Rev 03
This Chemical Type CEP, issued on December 08, 2015, remains in force until May 21, 2021, ensuring its reliability within the pharmaceutical industry.
Substance Number 108 associated with this CEP further emphasizes